Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeSEASUN BIOMATERIALSKorean Based Company to Launch COVID-19 Rapid Molecular Assay

Korean Based Company to Launch COVID-19 Rapid Molecular Assay

Korean based SEASUN BIOMATERIALS announced that they are about to release their second COVID-19 assay “AQ-TOP COVID-19 Rapid Detection Kit” just after the completion of FDA EUA (April-27) of their U-TOP COVID-19 Real-Time Detection Kit.

Analytical Speed, Sensitivity and Specificity of the conventional molecular methods were enhanced with AQ-TOP technology through the combination of isothermal amplification and PNA (Peptide Nucleic Acid) detection probewhich has high accurate binding efficiency to the target nucleic acid.

This kit targets ORF1ab gene of SARS-CoV-2 with an endogenous control human RNase P gene. The kit obtained CE-IVD marking in March, and now examinations of an export approval of MFDS (Korea’s Ministry of Food & Drug Safetyand the FDA EUA are underway.

CEO Hee-Kyung Park said, “Customers don’t need to purchase an additional equipment. The existing real-time PCR instrument which is frequently used for COVID-19 diagnosis can be used as it is. The average number of specimens that can be tested per unit (12 hours per day) is 3,400, which is 5-6 times faster than before. Currently, as COVID-19 is rapidly spreading globally and re-infection is reported frequently, we will produce more than 200,000 tests per day to deliver as fast as possible. As soon as the permit for the AQ-TOP COVID-19 Rapid Detection Kit has been completed, the kit will be provided globally and with the advantage that the rapid COVID-19 diagnosis will contribute to quick follow-up.”

SEASUN BIOMATERIALS is currently distributing its real-time PCR based “U-TOP COVID-19 Detection Kit” which acquired CE-IVD marking, Certificate of Free Sales of MFDS (in February) and the FDA-EUA (on April-27), to overseas including Europe and the Middle Eastern countries.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy